Aim: The current study sought to determine which types of cognitive function are related to atrophy of the bilateral medial temporal areas including the entorhinal cortex (MTA-ERC) in elderly adults. Methods: The subjects were 96 elderly adults (mean age 75.3 years) with mild cognitive impairment. Subjects underwent Wechsler Memory Scale-Revised, logical memory I and II (WMS-R, LM I and II), Rey complex figure retention tests after 3 and 30 min (RCF-3 min and RCF-30 min), digit span backword (DSB), digit symbol-coding (DSC), Stroop Color and Word Test-Interference List (SCWT-IL) as well as magnetic resonance imaging (MRI) and were divided into elderly adults without or with mild to moderate MTA-ERC atrophy, and those with severe atrophy. Results: In all subjects, MTA-ERC atrophy showed significant relationships with age (r = 0.43), education (r = –0.25), WMS-R, LM I (r = –0.21), DSC (r = –0.32), and SCWT-IL (r = 0.32). The mild to moderate atrophy group showed significant relationships between MTA-ERC atrophy and age (r = 0.34), DSC (r = –0.28), and SCWT-IL (r = 0.25). In contrast, in the severe atrophy group, MTA-ERC atrophy was correlated significantly with RCF-3 min (r = –0.70) and RCF-30 min (r = –0.74). The linear regression model included demographic variables and cognitive tests; two variables to survive the step-wise analysis were age (β = 0.374) and SCWT-IL (β = 0.247) in all subjects. Age (β = 0.301), and RCF-30 min (β = –0.521) and age (β = 0.460) remained as a significant variable in the mild to moderate atrophy and severe atrophy groups, respectively. Conclusion: Executive function tests such as SCWT-IL may be useful as a screening tool to identify mild to moderate MTA-ERC atrophy and a decline in the RCF test may suggest severe MTA-ERC atrophy in elderly adults with MCI.

1.
Apostolova LG, Lu P, Rogers S, et al: 3D mapping of language networks in clinical and pre-clinical Alzheimer’s disease. Brain Lang 2008;104:33–41.
2.
Galton CJ, Patterson K, Graham K, et al: Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia. Neurology 2001;57:216–225.
3.
Grossman M, McMillan C, Moore P, et al: What’s in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer’s disease, frontotemporal dementia and corticobasal degeneration. Brain 2004;127:628–649.
4.
Van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, et al: Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old age. Dement Geriatr Cogn Disord 2005;20:82–88.
5.
Ries ML, Carlsson CM, Rowley HA, et al: Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc 2008;56:920–934.
6.
Jack CR Jr, Petersen RC, Xu YC, et al: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397–1403.
7.
Jack CR Jr, Petersen RC, Xu Y, et al: Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000;55:484–489.
8.
Jack CR Jr, Shiung MM, Weigand SD, et al: Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005;65:1227–1231.
9.
Killiany RJ, Hyman BT, Gomez-Isla T, et al: MRI measures of entorhinal cortex vs. hippocampus in preclinical AD. Neurology 2002;58:1188–1196.
10.
Cardenas VA, Chao LL, Studholme C, et al: Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol Aging 2011;32:572–580.
11.
Mungas D, Jagust WJ, Reed BR, et al: MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 2001;57:2229–2235.
12.
Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR: Detecting dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Geriatr Cogn Disord 2004;17:42–48.
13.
Storandt M, Grant EA, Miller JP, Morris JC: Rates of progression in mild cognitive impairment and early Alzheimer’s disease. Neurology 2002;59:1034–1041.
14.
Taler V, Phillips NA: Language performance in Alzheimer’s disease and mild cognitive impairment: a comparative review. J Clin Exp Neuropsychol 2008;30:501–556.
15.
Belleville S, Chertkow H, Gauthier S: Working memory and control of attention in persons with Alzheimer’s disease and mild cognitive impairment. Neuropsychology 2007;21:458–469.
16.
Chang YL, Jacobson MW, Fennema-Notestine C, et al: Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness. Cereb Cortex 2010;20:1305–1313.
17.
Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT: Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J Neurosci 1996;16:4491–4500.
18.
Killiany RJ, Gomez-Isla T, Moss M, et al: Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease. Ann Neurol 2000;47:430–439.
19.
Matsuda H: Role of neuroimaging in Alzheimer’s disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007;48:1289–1300.
20.
Matsuda H: The role of neuroimaging in mild cognitive impairment. Neuropathology 2007;27:570–577.
21.
Hirata Y, Matsuda H, Nemoto K, et al: Voxel-based morphometry to discriminate early Alzheimer’s disease from controls. Neurosci Lett 2005;382:269–274.
22.
Li X, Shimizu S, Jibiki I, Watanabe K, Kubota T: Correlations between Z-scores of VSRAD and regional cerebral blood flow of SPECT in patients with Alzheimer’s disease and mild cognitive impairment. Psychiatry Clin Neurosci 2010;64:284–292.
23.
Nagata T, Shinagawa S, Ochiai Y, et al: Association between executive dysfunction and hippocampal volume in Alzheimer’s disease. Int Psychogeriatr 2010:1–8.
24.
Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–194.
25.
Ashburner J, Friston K: Multimodal image coregistration and partitioning – a unified framework. Neuroimage 1997;6:209–217.
26.
Ashburner J, Friston KJ: Voxel-based morphometry – the methods. Neuroimage 2000;11:805–821.
27.
Wechsler D, Stone C: Wechsler Memory Scale Manual. New York, Psychological Corporation, 1973.
28.
Wechsler D: Wechsler Adult Intelligence Scale-III. San Antonio, Psychological Corporation, 1997.
29.
Stroop JR: Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643–662.
30.
Osterrieth P, Rey A: Le test de copie d’une figure complexe. Arch Psychol 1944;30:205–221.
31.
Corwin J, Bylsma FW: Translations of excerpts from Andre Rey’s psychological examination of traumatic encephalopathy and P.A. Osterrieth’s the complex figure copy test. Clin Neuropsychol 1993;7:3–21.
32.
Lezak MD: Neuropsychological Assessment, ed 4. New York, Oxford University Press, 2004.
33.
Squire LR, Zola SM: Amnesia, memory and brain systems. Philos Trans R Soc Lond B Biol Sci 1997;352:1663–1673.
34.
Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL: Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168–1170.
35.
Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239–259.
36.
Zola-Morgan S, Squire LR, Ramus SJ: Severity of memory impairment in monkeys as a function of locus and extent of damage within the medial temporal lobe memory system. Hippocampus 1994;4:483–495.
37.
Pennanen C, Kivipelto M, Tuomainen S, et al: Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004;25:303–310.
38.
Gur RC, Mozley PD, Resnick SM, et al: Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc Natl Acad Sci USA 1991;88:2845–2849.
39.
Blatter DD, Bigler ED, Gale SD, et al: Quantitative volumetric analysis of brain MR: normative database spanning five decades of life. Am J Neuroradiol 1995;16:241–251.
40.
Mueller EA, Moore MM, Kerr DC, et al: Brain volume preserved in healthy elderly through the eleventh decade. Neurology 1998;51:1555–1562.
41.
Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS: A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21–36.
42.
Mu Q, Xie J, Wen Z, Weng Y, Shuyun Z: A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. Am J Neuroradiol 1999;20:207–211.
43.
Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC: A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003;60:989–994.
44.
Karp A, Kareholt I, Qiu C, Bellander T, Winblad B, Fratiglioni L: Relation of education and occupation-based socioeconomic status to incident Alzheimer’s disease. Am J Epidemiol 2004;159:175–183.
45.
Ott A, Breteler MM, van Harskamp F, et al: Prevalence of Alzheimer’s disease and vascular dementia: association with education: the Rotterdam Study. BMJ 1995;310:970–973.
46.
Cobb JL, Wolf PA, Au R, White R, D’Agostino RB: The effect of education on the incidence of dementia and Alzheimer’s disease in the Framingham Study. Neurology 1995;45:1707–1712.
47.
Reed BR, Mungas D, Farias ST, et al: Measuring cognitive reserve based on the decomposition of episodic memory variance. Brain 2010;133:2196–2209.
48.
Cohen JD, Botvinick M, Carter CS: Anterior cingulate and prefrontal cortex: who’s in control? Nat Neurosci 2000;3:421–423.
49.
Hazeltine E, Poldrack R, Gabrieli JD: Neural activation during response competition. J Cognitive Neurosci 2000;12(suppl 2):118–129.
50.
Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD: Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998;280:747–749.
51.
Carter CS, Macdonald AM, Botvinick M, et al: Parsing executive processes: strategic vs. evaluative functions of the anterior cingulate cortex. Proc Natl Acad Sci USA 2000;97:1944–1948.
52.
Kerns JG, Cohen JD, MacDonald AW 3rd, Cho RY, Stenger VA, Carter CS: Anterior cingulate conflict monitoring and adjustments in control. Science 2004;303:1023–1026.
53.
Luks TL, Oliveira M, Possin KL, et al: Atrophy in two attention networks is associated with performance on a flanker task in neurodegenerative disease. Neuropsychologia 2010;48:165–170.
54.
Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F: Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on dementia. Eur Arch Psychiatry Clin Neurosci 1996;246:137–146.
55.
Wang L, Goldstein FC, Veledar E, et al: Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging. Am J Neuroradiol 2009;30:893–899.
56.
Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA: Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain 1992;115:1543–1561.
57.
Delbeuck X, Van der Linden M, Collette F: Alzheimer’s disease as a disconnection syndrome? Neuropsychol Rev 2003;13:79–92.
58.
Sorg C, Riedl V, Muhlau M, et al: Selective changes of resting-state networks in individuals at risk for Alzheimer’s disease. Proc Natl Acad Sci USA 2007;104:18760–18765.
59.
Buckner RL, Snyder AZ, Shannon BJ, et al: Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005;25:7709–7717.
60.
Meguro K, LeMestric C, Landeau B, Desgranges B, Eustache F, Baron JC: Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer’s disease: a PET/MRI correlative study. J Neurol Neurosurg Psychiatry 2001;71:315–321.
61.
Greicius MD, Srivastava G, Reiss AL, Menon V: Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637–4642.
62.
Bai F, Zhang Z, Yu H, et al: Default-mode network activity distinguishes amnestic type mild cognitive impairment from healthy aging: a combined structural and resting-state functional MRI study. Neurosci Lett 2008;438:111–115.
63.
Persson J, Lind J, Larsson A, et al: Altered deactivation in individuals with genetic risk for Alzheimer’s disease. Neuropsychologia 2008;46:1679–1687.
64.
Rombouts SA, Barkhof F, Goekoop R, Stam CJ, Scheltens P: Altered resting state networks in mild cognitive impairment and mild Alzheimer’s disease: an fMRI study. Hum Brain Mapp 2005;26:231–239.
65.
Zhang Y, Schuff N, Jahng GH, et al: Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007;68:13–19.
66.
Grambaite R, Selnes P, Reinvang I, et al: Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts. J Alzheimers Dis 2011;27:453–462.
67.
Barbas H, Pandya DN: Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey. J Comp Neurol 1989;286:353–375.
68.
Preuss TM, Goldman-Rakic PS: Connections of the ventral granular frontal cortex of macaques with perisylvian premotor and somatosensory areas: anatomical evidence for somatic representation in primate frontal association cortex. J Comp Neurol 1989;282:293–316.
69.
Barbas H: Architecture and cortical connections of the prefrontal cortex in the rhesus monkey. Adv Neurol 1992;57:91–115.
70.
Petrides M, Pandya DN: Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur J Neurosci 1999;11:1011–1036.
71.
Arikuni T, Sako H, Murata A: Ipsilateral connections of the anterior cingulate cortex with the frontal and medial temporal cortices in the macaque monkey. Neurosci Res 1994;21:19–39.
72.
Barbas H: Complementary roles of prefrontal cortical regions in cognition, memory, and emotion in primates. Adv Neurol 2000;84:87–110.
73.
Gleissner U, Helmstaedter C, Elger CE: Right hippocampal contribution to visual memory: a presurgical and postsurgical study in patients with temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1998;65:665–669.
74.
Milner A: Visually-guided maze learning in man: effects of bilateral hippocampal, bilateral frontal, and unilateral cerebral lesions. Neuropsychologia 1965;3:317–338.
75.
Lu PH, Thompson PM, Leow A, et al: Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis 2011;23:433–442.
76.
Wolf H, Kruggel F, Hensel A, Wahlund LO, Arendt T, Gertz HJ: The relationship between head size and intracranial volume in elderly subjects. Brain Res 2003;973:74–80.
77.
Larson EB, Wang L, Bowen JD, et al: Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006;144:73–81.
78.
Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K: A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 2001;161:1703–1708.
79.
Stummer W, Weber K, Tranmer B, Baethmann A, Kempski O: Reduced mortality and brain damage after locomotor activity in gerbil forebrain ischemia. Stroke 1994;25:1862–1869.
80.
Carro E, Trejo JL, Busiguina S, Torres-Aleman I: Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 2001;21:5678–5684.
81.
Black JE, Isaacs KR, Anderson BJ, Alcantara AA, Greenough WT: Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. Proc Natl Acad Sci USA 1990;87:5568–5572.
82.
Cotman CW, Berchtold NC: Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002;25:295–301.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.